|
USP16 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.364710E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.018400E-03 |
| Normal-vs-Stage2 |
1.804580E-01 |
| Normal-vs-Stage3 |
5.416400E-04 |
| Normal-vs-Stage4 |
9.85310000000128E-05 |
| Stage1-vs-Stage2 |
7.476200E-01 |
| Stage1-vs-Stage3 |
2.363600E-01 |
| Stage1-vs-Stage4 |
9.763800E-02 |
| Stage2-vs-Stage3 |
2.999200E-01 |
| Stage2-vs-Stage4 |
2.109800E-01 |
| Stage3-vs-Stage4 |
6.841600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.442200E-04 |
| Normal-vs-AfricanAmerican |
1.462550E-03 |
| Normal-vs-Asian |
3.800100E-02 |
| Caucasian-vs-AfricanAmerican |
5.176400E-01 |
| Caucasian-vs-Asian |
5.853400E-01 |
| AfricanAmerican-vs-Asian |
7.467400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.846520E-04 |
| Normal-vs-Female |
1.358660E-03 |
| Male-vs-Female |
6.921600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.060800E-03 |
| Normal-vs-Age(41-60Yrs) |
7.757900E-03 |
| Normal-vs-Age(61-80Yrs) |
6.44289999999215E-05 |
| Normal-vs-Age(81-100Yrs) |
5.297800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.869600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.138400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.118200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.961020E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.727800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.321200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.017200E-01 |
| Normal-vs-Grade 2 |
5.472000E-02 |
| Normal-vs-Grade 3 |
2.04109999999424E-05 |
| Normal-vs-Grade 4 |
5.43309999989638E-07 |
| Grade 1-vs-Grade 2 |
8.047800E-01 |
| Grade 1-vs-Grade 3 |
1.955200E-01 |
| Grade 1-vs-Grade 4 |
3.580100E-02 |
| Grade 2-vs-Grade 3 |
1.109970E-02 |
| Grade 2-vs-Grade 4 |
3.562400E-04 |
| Grade 3-vs-Grade 4 |
9.472000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.291800E-01 |
| Normal-vs-ccB subtype |
1.95415999999504E-05 |
| ccA subtype-vs-ccB subtype |
4.360300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.153100E-04 |
| Normal-vs-N1 |
3.002000E-03 |
| N0-vs-N1 |
3.417000E-01 |
|
|
